Xenon Pharmaceuticals
XENE
#3698
Rank
A$5.19 B
Marketcap
A$67.25
Share price
-1.07%
Change (1 day)
2.36%
Change (1 year)

Revenue for Xenon Pharmaceuticals (XENE)

Revenue in 2025 (TTM): A$12.01 Million

According to Xenon Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is A$11.32 Million. In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Xenon Pharmaceuticals from 2014 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) A$12.01 M
2024 N/A
2023 N/A-100%
2022 A$13.86 M-45.49%
2021 A$25.43 M-39.21%
2020 A$41.83 M328.88%
2019 A$9.75 M
2018 N/A-100%
2017 A$0.39 M-84.07%
2016 A$2.5 M-88.3%
2015 A$21.38 M-38.32%
2014 A$34.66 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Coherus BioSciences
CHRS
A$0.12 B 1,014.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Atara Biotherapeutics
ATRA
A$0.28 B 2,415.56%๐Ÿ‡บ๐Ÿ‡ธ USA